FL118, a novel camptothecin derivative, is insensitive to ABCG2 expression and shows improved efficacy in comparison with irinotecan in colon and lung cancer models with ABCG2-induced resistance
Crossref DOI link: https://doi.org/10.1186/s12943-015-0362-9
Published Online: 2015-04-28
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Westover, David
Ling, Xiang
Lam, Hong
Welch, Jacob
Jin, Chunyang
Gongora, Celine
Del Rio, Maguy
Wani, Mansukh
Li, Fengzhi
License valid from 2015-04-28
Article History
Received: 17 November 2014
Accepted: 7 April 2015
First Online: 28 April 2015